Patient satisfactory score post oncoplastic breast surgery- our institutional experience
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20231226Keywords:
Oncoplastic breast surgeryAbstract
Background: Surgical management of breast cancer is rapidly evolving with increasing importance on techniques to preserve patient’s quality of life and post treatment cosmesis. Oncoplastic breast surgery (OBS) combines oncologic principles with plastic surgery techniques to improve cosmetic results by immediate breast reconstruction at the time of surgery. We aimed to evaluate patient reported satisfaction using questionnaire following OBS.
Methods: This was a prospective observational study of 25 patients who underwent oncoplastic breast surgery at the department of surgical oncology, Government Royapettah hospital, Kilpauk Medical College Chennai, between 2021 January - September 2022. Patients who underwent OBS were given the questionnaire (BREAST-Q) directed specifically on satisfaction with breast cosmesis at one month postoperatively.
Results: Mean satisfactory score was 42.4 (highly satisfied), 5 out of 25 (20%) patients responded with a score of 50/50. The patient with a minimum score of 26/50, had undergone wise pattern mammoplasty for giant fibroadenoma and had nipple areola complex necrosis postoperatively. No major complications were noted in other patients.
Conclusions: OBS is emerging as the standard of care in India for early breast cancer, although time taken is longer than the west. Long term outcomes in the Indian population are yet to emerge. Our results demonstrate a high satisfaction with breasts cosmesis in patients who underwent OBS.
References
Schover LR. The impact of breast cancer on sexuality, body image, and intimate relationships. CA Cancer J Clin. 1991; 41(2):112-20.
Litière S, Werutsky G, Fentiman IS. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13:412-9.
Rose M, Manjer J, Ringberg A, Svensson H. Surgical strategy, methods of reconstruction, surgical margins and postoperative complications in oncoplastic breast surgery. Eur J Plast Surg. 2014;37:205-14.
Klit A, Tvedskov TF, Kroman N, Elberg JJ, Ejlertsen B, Henriksen TF. Oncoplastic breast surgery does not delay the onset of adjuvant chemotherapy: a population-based study. Acta Oncol. 2017;56(5):719-23.
Losken A, Dugal CS, Styblo TM, Carlson GW. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg. 2014;72(2):145-9.
Dahlbäck C, Manjer J, Rehn M, Ringberg A. Determinants for patient satisfaction regarding aesthetic outcome and skin sensitivity after breast-conserving surgery. World J Surg Oncol. 2016;14(1):1-1.
Cetintas SK, Ozkan L, Kurt M, Saran A, Tasdelen I, Tolunay S, et al. Factors influencing cosmetic results after breast conserving management (Turkish experience). Breast. 2002;11:72-80.
Johansen J, Overgaard J, Rose C, Engelholm SA, Gadeberg CC, Kjaer M, et al. Cosmetic outcome and breast morbidity in breast-conserving treatment-results from the Danish DBCG-82TM national randomized trial in breast cancer. Acta Oncol. 2002;41:369-80.
Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia DM, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 1995;31:753-64.
Sneeuw KC, Aaronson NK, Yarnold JR, Broderick M, Regan J, Ross G, et al. Cosmetic and functional outcomes of breast conserving treatment for early-stage breast cancer. 1. Comparison of patients’ ratings, observers’ ratings, and objective assessments. Radiother Oncol. 1992;25:153-9.
Beadle GF, Silver B, Botnick L, Hellman S, Harris JR. Cosmetic results following primary radiation therapy for early breast cancer. Cancer. 1984;54:2911-8.
Markiewicz DA, Schultz DJ, Haas JA, Harris EE, Fox KR, Glick JH, et al. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. Int J Radiat Oncol Biol Phys. 1996;35:661-8.
Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER, et al. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys. 1996;35:669-77.
